Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 9692304, 8 pages
https://doi.org/10.1155/2017/9692304
Research Article

Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate Nodules

1Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
2Department of Radiological, Oncological and Anatomo-Pathological Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
3Department of Experimental Medicine, “Sapienza” University of Rome, 00161 Rome, Italy
4Department of Public Health and Infectious Disease, “Sapienza” University of Rome, 00161 Rome, Italy

Correspondence should be addressed to Salvatore Ulisse; ti.1amorinu@essilu.erotavlas

Received 5 September 2016; Revised 7 November 2016; Accepted 26 December 2016; Published 1 March 2017

Academic Editor: Giorgio Iervasi

Copyright © 2017 Salvatore Ulisse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Roman, “Endocrine tumors: evaluation of the thyroid nodule,” Current Opinion in Oncology, vol. 15, no. 1, pp. 66–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Welker and D. Orlov, “Thyroid nodules,” American Family Physician, vol. 67, no. 3, pp. 559–566, 2003. View at Google Scholar
  3. B. R. Haugen, E. K. Alexander, K. C. Bible et al., “2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. I. Sherman, “Thyroid carcinoma,” Lancet, vol. 361, no. 9356, pp. 501–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Soderstrom, “Puncture of goiter for aspiration biopsy,” Acta Medica Scandinavica, vol. 144, no. 3, pp. 237–241, 1952. View at Publisher · View at Google Scholar
  6. H. Gharib, “Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect,” Mayo Clinic Proceedings, vol. 69, no. 1, pp. 44–49, 1994. View at Publisher · View at Google Scholar
  7. J. I. Hamburger, “Diagnosis thyroid nodules by fine needle biopsy: use and abuse,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 2, pp. 335–339, 1994. View at Publisher · View at Google Scholar
  8. J. F. Nasuti, P. K. Gupta, and Z. W. Baloch, “Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases,” Diagnostic Cytopathology, vol. 27, no. 1, pp. 1–4, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. W. Baloch, S. Fleisher, V. A. LiVolsi, and P. K. Gupta, “Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiration cytology,” Diagnostic Cytopathology, vol. 26, no. 1, pp. 41–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Salvatore, R. Giannini, P. Faviana et al., “Analysis of BRAF point mutation and RET/PTC rearrangements refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 10, pp. 5175–5180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Leidig-Bruckner, G. Cichorowski, P. Sattler, T. Bruckner, and B. Sattler, “Evaluation of thyroid nodules—combined use of 99mTc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy—a retrospective study,” Clinical Endocrinology, vol. 76, no. 5, pp. 749–758, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Deandreis, A. Al Ghuzian, A. Auperin et al., “Is 18F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?” Thyroid, vol. 22, no. 2, pp. 165–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sorrenti, P. Trimboli, A. Catania, S. Ulisse, E. De Antoni, and M. D'Armiento, “Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürtle cell neoplasm,” Thyroid, vol. 19, no. 4, pp. 355–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Cantisani, S. Ulisse, E. Guaitoli et al., “Q-elastography in the presurgical diagnosis of thyroid nodules with indeterminate cytology,” PloS One, vol. 7, no. 11, p. e50725, 2012. View at Publisher · View at Google Scholar
  15. P. Trimboli, S. Ulisse, M. D'Alò et al., “Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasms,” Clinical Endocrinology, vol. 69, no. 2, pp. 342–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Y. Kwak, K. H. Han, J. H. Yoon et al., “Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk,” Radiology, vol. 260, no. 3, pp. 892–899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Jameson, “Minimizing unnecessary surgery for thyroid nodules,” New England Journal of Medicine, vol. 367, no. 8, pp. 765–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. E. Nikiforov, N. P. Ohori, S. P. Hodak et al., “Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 11, pp. 3390–3397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Moses, J. Weng, I. Sansano et al., “Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy,” World Journal of Surgery, vol. 34, no. 11, pp. 2589–2594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Chudova, J. I. Wild, E. T. Wang et al., “Molecular classification of thyroid nodules using high-dimensionality genomic data,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5296–5304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. K. Alexander, G. C. Kennedy, Z. W. Baloch et al., “Preoperative diagnosis of benign thyroid nodules with indeterminate cytology,” New England Journal of Medicine, vol. 367, no. 8, pp. 705–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. S. Walsh, J. I. Wild, E. Y. Tom et al., “Analytical performance verification of a molecular diagnostic for cytology-indeterminate thyroid nodules,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 12, pp. E2297–E2306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. S. Cibas and S. Z. Ali, “The Bethesda System for Reporting Thyroid Cytopathology,” Thyroid, vol. 19, no. 11, pp. 1159–1165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Nardi, F. Basolo, A. Crescenzi et al., “Italian consensus for the classification and reporting of thyroid cytology,” Journal of Endocrinological Investigation, vol. 37, no. 6, pp. 593–599, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Perros, S. Colley, K. Boelaert et al., “Guidelines for the management of thyroid cancer,” Clinical Endocrinology, vol. 81, Supplement 1, pp. 1–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Fadda, F. Basolo, A. Bondi et al., “Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group,” Pathologica, vol. 102, no. 5, pp. 405–406, 2010. View at Google Scholar
  27. H. Gharib, E. Papini, J. R. Garber et al., “American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules—2016 update,” Endocrine Practice, vol. 22, no. 5, pp. 622–639, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. Cross, A. Chandra, T. Giles et al., The Royal College of Pathologists. Guidance on the reporting of thyroid cytology specimens, 2009, http://ukeps.com/docs/thyroidfna.pdf View at Publisher · View at Google Scholar
  29. C. Hedinger, E. D. Williams, and L. H. Sobin, “The WHO histological classification of thyroid tumors: a commentary on the second edition,” Cancer, vol. 63, no. 5, pp. 908–911, 1989. View at Publisher · View at Google Scholar
  30. C. Brophy, R. Mehanna, J. McCarthy, A. Tuthill, M. S. Murphy, and P. Sheahan, “Outcome of subclassification of indeterminate (Thy-3) thyroid cytology into Thy-3a and Thy-3f,” European Thyroid Journal, vol. 4, no. 4, pp. 246–251, 2015. View at Publisher · View at Google Scholar
  31. P. Straccia, E. D. Rossi, T. Bizzarro et al., “A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated?” Cancer Cytopathology, vol. 123, no. 12, pp. 713–722, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. M. T. Olson, T. Boonyaarunnate, P. Aragon Han, C. B. Umbricht, S. Z. Ali, and M. A. Zeiger, “A tertiary center’s experience with second review of 3885 thyroid cytopathology specimens,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. 1450–1457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Horne, D. C. Chhieng, C. Theoharis et al., “Thyroid follicular lesions of undetermined significance: evaluation of the risk of malignancy using the 2-tier subclassification,” Diagnostic Cytopathology, vol. 40, no. 5, pp. 410–415, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Nishino and H. H. Wang, “Should the thyroid AUS/FLUS category be further stratified by malignancy risk?” Cancer Cytopathology, vol. 122, no. 7, pp. 481–483, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Gerhard and S. L. Boemer, “The value of second opinion in thyroid cytology: a review,” Cancer Cytopathology, vol. 122, no. 8, pp. 611–619, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Jing, S. M. Knoepp, M. H. Roh et al., “Group consensus review minimizes the diagnosis of “follicular lesion of undetermined significance” and improves cytohistologic concordance,” Diagnostic Cytopathology, vol. 40, no. 12, pp. 1037–1042, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Kocjan, A. Chandra, P. A. Cross et al., “The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists’ classification system,” American Journal of Clinical Pathology, vol. 135, no. 6, pp. 852–859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. F. F. R. Maia, P. S. Matos, E. J. Pavin, and D. E. Zantut-Wittmann, “Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology,” Clinical Endocrinology, vol. 82, no. 3, pp. 439–444, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. C. L. Chng, T. R. Kurzawinski, and T. Beale, “Value of sonographic features in predicting malignancy in thyroid nodules diagnosed as follicular neoplasm on cytology,” Clinical Endocrinology, vol. 83, no. 5, pp. 711–716, 2015. View at Publisher · View at Google Scholar · View at Scopus